A recent review of ASX largest companies highlights that CSL has slipped from number 3 to number 5 on the ladder.
Wesfarmers to roll them next
one impact is that the major index funds will be required to sell CSL to buy up on the stocks overtaking them.
I expect CSL to drift back below $200 in the forseeable, so further index selling pressure to come.
CSL did spend $18.8 billion on a kidney business in Europe in 2022 and that now doesn’t feel like it can be firing up as expected … so auditors may require some impairment in the near future.
—//— AFR quote Oct 2022 at time of purchase … leading analyst thought there could have been greater transparency about the reasoning of making that large transaction
CSL Price at posting:
$208.37 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)